Filing Details

Accession Number:
0000899243-16-024049
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-01 16:06:19
Reporting Period:
2016-06-30
Filing Date:
2016-07-01
Accepted Time:
2016-07-01 16:06:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1174940 Oragenics Inc OGEN.BC Pharmaceutical Preparations (2834) 593410522
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234877 Beverly Koski 3525 Turtle Creek Bouldevard, Unit 19-B
Dallas TX 75219
No No Yes No
1234878 L Christine Koski 3525 Turtle Creek Bouldevard, Unit 19-B
Dallas TX 75219
No No Yes No
1234879 Koski Family Lp 3525 Turtle Creek Boulevard, Unit 19-B
Dallas TX 75219
No No Yes No
1234880 C Robert Koski 7362 Hawkins Road
Sarasota FL 34241
Yes No Yes No
1234881 L Thomas Koski 4995 Ashley Parkway
Sarasota FL 34241
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-30 5,815,080 $0.52 12,864,822 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,572,523 Direct
Common Stock 1,007,878 Direct
Common Stock 919,666 Direct
Common Stock 28,000 Indirect By Koski Management, Inc.
Common Stock 530,851 Indirect By Trusts
Footnotes
  1. The shares were acquired pursuant to a private placement conducted by the Company.
  2. Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
  3. Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
  4. Shares owned directly by Christine L. Koski.
  5. Shares owned directly by Robert C. Koski, a director of the Company.
  6. Shares owned directly by Thomas L. Koski.
  7. Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
  8. Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.